SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells

Cancer Immunology, Immunotherapy

Volumn 61, Issue 3, 2012, Pages 303-312

  Wei, Jing Jing ^a   Song, Chuan Wang ^a   Sun, Ling Cong ^a   Yuan, Ye ^a   Li, Dong ^a   Yan, Bin ^a   Liao, Sheng Jun ^a   Zhu, Jian Hua ^a   Wang, Qi ^a   Zhang, Gui Mei ^a   Feng, Zuo Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

GSK3 ; Mast cells; Stem cell factor; Toll like receptor 4; Tumor

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; SERINE; STEM CELL FACTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 LIGAND; TYROSINE; UNCLASSIFIED DRUG; VASCULOTROPIN; CROMOGLYCATE DISODIUM; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LIGAND; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CANCER TISSUE; CELL DAMAGE; CELL FUNCTION; CELL SECRETION; CELL STIMULATION; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOMODULATION; MAST CELL; MAST CELL DEGRANULATION; METABOLIC INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL MOTION; DEGRANULATION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL DEGRANULATION; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CROMOLYN SODIUM; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN-10; INTERLEUKIN-12; LIGANDS; LIPOPOLYSACCHARIDES; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL FACTOR; TOLL-LIKE RECEPTOR 4; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

EID: 84860812876     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1098-z     Document Type: Article

References (39)

1. Conti P, Castellani ML, Kempuraj D, Salini V, Vecchiet J, Tetè S et al (2007) Role of mast cells in tumor growth. Ann Clin Lab Sci 37:315-322 (Pubitemid 350105931)
2. Maltby S, Khazaie K, McNagny KM (2009) Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 1796:19-26
3. Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM (2008) A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29:880-886 (Pubitemid 351494179)
4. Henderson WR, Chi EY, Jong EC, Klebanoff SJ (1981) Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med 153:520-533 (Pubitemid 11155792)
5. Kormelink TG, Abudukelimu A, Redegeld FA (2009) Mast cells as target in cancer therapy. Curr Pharm Des 15:1868-1878
6. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13:1211-1218 (Pubitemid 47530639)
7. Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S, Sirigu P (2003) Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33:420-425 (Pubitemid 36583711)
8. Ribatti D, Crivellato E (2009) The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol 275:89-131
9. Ullrich SE, Nghiem DX, Khaskina P (2007) Suppression of an established immune response by UVA - a critical role for mast cells. Photochem Photobiol 83:1095-1100 (Pubitemid 47438536)
10. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8:1095-1104 (Pubitemid 47423757)
11. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K et al (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997-1002 (Pubitemid 44330250)
12. Nakano N, Nishiyama C, Kanada S, Niwa Y, Shimokawa N, Ushio H, Nishiyama M, Okumura K, Ogawa H (2007) Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 109:4846-4855 (Pubitemid 46827781)
13. Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH (2008) SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112:1269-1279
14. + cells to induce apoptosis of activated T cells. J Immunol 185:2773-2782
15. Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C et al (2004) Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431:1007-1011 (Pubitemid 39434424)
16. Geng H, Zhang GM, Xiao H, Yuan Y, Li D, Zhang H, Qiu H, He YF, Feng ZH (2006) HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int J Cancer 118:2657-2664 (Pubitemid 43673341)
17. Walsh SK, Kane KA, Wainwright CL (2009) Mast cell degranulation - a mechanism for the anti-arrhythmic effect of endothelin-1? Br J Pharmacol 157:716-723
18. Tsan MF, Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76:514-519
19. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA (2006) FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107:610-618 (Pubitemid 43076385)
20. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175:3339-3346 (Pubitemid 41170555)
21. Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25:235-241 (Pubitemid 38501669)
22. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217:65-78 (Pubitemid 46718152)
23. Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6:777-784 (Pubitemid 43090463)
24. Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. Prog Neurobiol 65:391-426 (Pubitemid 32781670)
25. Miyashita K, Kawakami K, Nakada M, Mai W, Shakoori A, Fujisawa H, Hayashi Y, Hamada J, Minamoto T (2009) Potential therapeutic effect of glycogen synthase kinase 3 beta inhibition against human glioblastoma. Clin Cancer Res 15:887-897
26. + T cells through production of leukotriene B4. Nat Immunol 4:974-981
27. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, Szyfter W, Zeromski J, Whiteside TL (2009) Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 69:3105-3113
28. Yasuda A, Sawai H, Takahashi H, Ochi N, Matsuo Y, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T (2007) Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway. Dig Dis Sci 52:2292-2300 (Pubitemid 47246529)
29. Metcalfe DD, Peavy RD, Gilfillan AM (2009) Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 124:639-646
30. Kim MS, Rådinger M, Gilfillan AM (2008) The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol 29:493-501
31. Kalesnikoff J, Rios EJ, Chen CC, Nakae S, Zabel BA, Butcher EC, Tsai M, Tam SY, Galli SJ (2006) RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci USA 103:2659-2664
32. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166:3837-3845 (Pubitemid 32224909)
33. Ardeshna KM, Pizzey AR, Devereux S, Khwaja A (2000) The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide- stimulated human monocyte-derived dendritic cells. Blood 96:1039-1046 (Pubitemid 30616871)
34. Lawrence T (2007) Inflammation and cancer: a failure of resolution? Trends Pharmacol Sci 28:162-165
35. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867 (Pubitemid 36019639)
36. Lin WW, Karin MA (2007) Cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183 (Pubitemid 46718402)
37. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65:5009-5014 (Pubitemid 40827306)
38. Huang B, Lei Z, Zhao J, Gong W, Liu J, Chen Z, Liu Y, Li D, Yuan Y, Zhang GM, Feng ZH (2007) CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 252:86-92 (Pubitemid 46734559)
39. Shin HY, Kim JS, An NH, Park RK, Kim HM (2004) EVect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci 74:2877-2887